T. Rowe Price Associates’s Camden National CAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
29,573
+4,252
+17% +$199K ﹤0.01% 1982
2025
Q4
$1.1M Buy
25,321
+3,131
+14% +$126K ﹤0.01% 2044
2025
Q3
$857K Buy
22,190
+2,540
+13% +$102K ﹤0.01% 2133
2025
Q2
$798K Buy
19,650
+924
+5% +$36.2K ﹤0.01% 2083
2025
Q1
$758K Buy
18,726
+1,413
+8% +$60.9K ﹤0.01% 2079
2024
Q4
$740K Buy
17,313
+918
+6% +$40.5K ﹤0.01% 2108
2024
Q3
$678K Sell
16,395
-1,412
-8% -$53.5K ﹤0.01% 2127
2024
Q2
$588K Buy
17,807
+1,536
+9% +$48.5K ﹤0.01% 2126
2024
Q1
$546K Buy
16,271
+4,907
+43% +$166K ﹤0.01% 2173
2023
Q4
$428K Sell
11,364
-1,631
-13% -$53.2K ﹤0.01% 2245
2023
Q3
$367K Buy
12,995
+494
+4% +$16K ﹤0.01% 2258
2023
Q2
$388K Buy
12,501
+955
+8% +$30.5K ﹤0.01% 2249
2023
Q1
$418K Buy
11,546
+334
+3% +$13.5K ﹤0.01% 2183
2022
Q4
$467K Buy
11,212
+1,533
+16% +$65.2K ﹤0.01% 2155
2022
Q3
$413K Buy
9,679
+838
+9% +$38.1K ﹤0.01% 2220
2022
Q2
$389K Buy
8,841
+86
+1% +$3.86K ﹤0.01% 2327
2022
Q1
$412K Buy
8,755
+2,590
+42% +$128K ﹤0.01% 2426
2021
Q4
$297K Sell
6,165
-215
-3% -$10.3K ﹤0.01% 2594
2021
Q3
$306K Sell
6,380
-6,954
-52% -$320K ﹤0.01% 2572
2021
Q2
$637K Sell
13,334
-4,086
-23% -$194K ﹤0.01% 2276
2021
Q1
$834K Sell
17,420
-1,302
-7% -$54.5K ﹤0.01% 2143
2020
Q4
$670K Buy
18,722
+1,500
+9% +$51.6K ﹤0.01% 2113
2020
Q3
$521K Sell
17,222
-400
-2% -$12.9K ﹤0.01% 2077
2020
Q2
$609K Buy
17,622
+401
+2% +$12.7K ﹤0.01% 1981
2020
Q1
$542K Buy
17,221
+7,823
+83% +$329K ﹤0.01% 1947
2019
Q4
$433K Buy
9,398
+590
+7% +$26.1K ﹤0.01% 2200
2019
Q3
$382K Buy
8,808
+82
+0.9% +$3.56K ﹤0.01% 2198
2019
Q2
$400K Buy
8,726
+28
+0.3% +$1.22K ﹤0.01% 2198
2019
Q1
$363K Buy
8,698
+40
+0.5% +$1.67K ﹤0.01% 2234
2018
Q4
$311K Buy
8,658
+27
+0.3% +$1.08K ﹤0.01% 2267
2018
Q3
$375K Hold
8,631
﹤0.01% 2265
2018
Q2
$395K Buy
8,631
+16
+0.2% +$724 ﹤0.01% 2248
2018
Q1
$383K Buy
8,615
+30
+0.3% +$1.3K ﹤0.01% 2188
2017
Q4
$362K Sell
8,585
-10
-0.1% -$435 ﹤0.01% 2215
2017
Q3
$375K Hold
8,595
﹤0.01% 2195
2017
Q2
$369K Hold
8,595
﹤0.01% 2162
2017
Q1
$379K Hold
8,595
﹤0.01% 2161
2016
Q4
$382K Hold
8,595
﹤0.01% 2162
2016
Q3
$274K Buy
8,595
+15
+0.2% +$455 ﹤0.01% 2256
2016
Q2
$240K Hold
8,580
﹤0.01% 2255
2016
Q1
$240K Hold
8,580
﹤0.01% 2242
2015
Q4
$252K Buy
8,580
+30
+0.4% +$854 ﹤0.01% 2215
2015
Q3
$230K Hold
8,550
﹤0.01% 2247
2015
Q2
$221K Hold
8,550
﹤0.01% 2309
2015
Q1
$227K Hold
8,550
﹤0.01% 2311
2014
Q4
$227K Buy
+8,550
New +$216K ﹤0.01% 2301
2014
Q3
Sell
-8,550
Closed -$221K 2548
2014
Q2
$221K Hold
8,550
﹤0.01% 2314
2014
Q1
$235K Hold
8,550
﹤0.01% 2261
2013
Q4
$241K Hold
8,550
﹤0.01% 2244
2013
Q3
$233K Buy
+8,550
New +$220K ﹤0.01% 2213

Other funds holding CAC

T. Rowe Price Associates's CAC Position: Q1 2026 in Review

T. Rowe Price Associates increased its Camden National (CAC) stake by 17% in Q1 2026, buying an estimated $199K and bringing the position to 29,573 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1982.

T. Rowe Price Associates first reported a position in CAC in Q3 2013 and has held it in 50 quarters since. 175 funds tracked by Wall St. Rank hold CAC as of Q1 2026.

  • T. Rowe Price Associates held 29,573 shares of Camden National worth $1.4M as of Q1 2026.
  • T. Rowe Price Associates bought 4,252 Camden National shares in Q1 2026, an estimated $199K.
  • Camden National made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1982 holding.
  • T. Rowe Price Associates first reported a position in Camden National in Q3 2013 and has held it in 50 quarters since.
  • 175 funds tracked by Wall St. Rank held Camden National as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.